Virginia Tech® home

Virtual Seminar: Targeting PIK3CA Mutant Cancers

Insert your title here

Your Text Here
Zhenghe Wang, Ph.D.

Zhenghe J. Wang, Ph.D.

Dale H. Cowan and Ruth Goodman Blum Professor of Cancer Research
Department of Genetics and Genome Sciences
Comprehensive Care Center
Case Western Reserve University

Virtual Pioneers in Biomedical Research Seminar: Targeting PIK3CA Mutant Cancers 

March 11, 2022

11:00 a.m. to 12:00 p.m.

View Speaker Profile
Download Flyer

About this Seminar

PIK3CA is the most frequently mutated oncogene in human cancers. Dr. Wang will present two projects that translate bench discoveries made in his laboratory into clinical trials to treat PIK3CA mutant colorectal cancer patients. The first approach targets glutamine addiction of PIK3CA mutant colorectal cancer, whereas the second approach combines drugs that target epigenetics and PI3K alpha.

Additional Details

This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.

You May Also Be Interested In...

  • Home Item
    The Role of Exercise in Memory Function
    The Role of Exercise in Memory Function , home

    May 23, 2025, 11:00 a.m. | Henriette van Praag, Ph.D., Associate Professor, Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University | Co-Sponsored by the Center for Exercise Medicine Research, Fralin Biomedical Research Institute

  • Home Item
    Pathways and Regulation of Cardiac Nav1.5 Channel Trafficking in Adult Myocytes
    Pathways and Regulation of Cardiac Nav1.5 Channel Trafficking in Adult Myocytes , home

    May 30, 2025, 11:00 a.m. | Gea-Ny Tseng, Ph.D., Professor, Department of Physiology and Biophysics, Virginia Commonwealth University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research

  • Home Item
    Targeting Acquired Dependencies During Tumor Evolution
    Targeting Acquired Dependencies During Tumor Evolution , home

    June 6, 2025, 11:00 a.m. | Kris Wood, Ph.D., Associate Professor, Department of Pharmacology and Cancer Biology, Duke University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.